7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine

C29H30N8 — CID 74956494

IUPAC7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
SMILESc1cc(-c2c(-c3ccncc3)nn3c(C4CCC(N5CC6CC5CN6)CC4)ccnc23)c2cn[nH]c2c1
InChIInChI=1S/C29H30N8/c1-2-23(24-16-33-34-25(24)3-1)27-28(19-8-11-30-12-9-19)35-37-26(10-13-31-29(27)37)18-4-6-21(7-5-18)36-17-20-14-22(36)15-32-20/h1-3,8-13,16,18,20-22,32H,4-7,14-15,17H2,(H,33,34)
InChIKeyIGEZRHKQPIHLJK-UHFFFAOYSA-N
MW490.62 g/mol
LogP4.41
Rot. Bonds4

About 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine

7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine (PubChem CID 74956494) has the molecular formula C29H30N8 and a molecular weight of 490.62 g/mol. Its IUPAC name is 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine.

Molecular Properties

Compound Name7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
PubChem CID74956494
Molecular FormulaC29H30N8
Molecular Weight490.62 g/mol
Exact Mass490.26
IUPAC Name7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
SMILESc1cc(-c2c(-c3ccncc3)nn3c(C4CCC(N5CC6CC5CN6)CC4)ccnc23)c2cn[nH]c2c1
InChIInChI=1S/C29H30N8/c1-2-23(24-16-33-34-25(24)3-1)27-28(19-8-11-30-12-9-19)35-37-26(10-13-31-29(27)37)18-4-6-21(7-5-18)36-17-20-14-22(36)15-32-20/h1-3,8-13,16,18,20-22,32H,4-7,14-15,17H2,(H,33,34)
InChIKeyIGEZRHKQPIHLJK-UHFFFAOYSA-N
XLogP4.41
TPSA87.03 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms37
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500490.62
LogP ≤ 54.41
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine?
The IUPAC name of 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine (CID 74956494) is 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine.
What is the SMILES notation for 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine?
The canonical SMILES for 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine is c1cc(-c2c(-c3ccncc3)nn3c(C4CCC(N5CC6CC5CN6)CC4)ccnc23)c2cn[nH]c2c1.
What is the InChIKey of 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine?
The InChIKey is IGEZRHKQPIHLJK-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H30N8/c1-2-23(24-16-33-34-25(24)3-1)27-28(19-8-11-30-12-9-19)35-37-26(10-13-31-29(27)37)18-4-6-21(7-5-18)36-17-20-14-22(36)15-32-20/h1-3,8-13,16,18,20-22,32H,4-7,14-15,17H2,(H,33,34).
What are the key properties of 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine?
7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine has a molecular weight of 490.62 g/mol, XLogP of 4.41, 4 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[4-(2,5-diazabicyclo[2.2.1]heptan-2-yl)cyclohexyl]-3-(1H-indazol-4-yl)-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidine is sourced from PubChem (CID 74956494), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).